Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians

The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report

Linda J. Burns, James L. Gajewski, Navneet S. Majhail, Willis Navarro, Miguel Angel Perales, Evan Shereck, George B. Selby, Edward L. Snyder, Ann E. Woolfrey, Mark R Litzow

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic, and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of HCT as a viable therapeutic option for older patients, those with significant comorbidities, and, with the demonstrated clinical effectiveness of alternative allogeneic donor sources, for those patients without a suitable sibling donor. The National Marrow Donor Program (NMDP) estimates that by 2020, it will facilitate 10,000 transplantations per year, double the number in 2010. To understand the needs of the HCT infrastructure to facilitate this number of transplantations, the NMDP organized the System Capacity Initiative 2020, centered on 6 working groups representing a diverse group of stakeholders. The Physician Workforce Group was tasked with addressing issues relating to recruitment and retention of transplantation physicians. We report here the results of our efforts and future initiatives.

Original languageEnglish (US)
Pages (from-to)617-621
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Cell Transplantation
Bone Marrow
Tissue Donors
Physicians
Transplantation
Comorbidity
Siblings
Therapeutics

Keywords

  • Hematopoietic cell transplantation
  • Physician workforce
  • Recruitment
  • Retention

ASJC Scopus subject areas

  • Transplantation
  • Hematology
  • Medicine(all)

Cite this

Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians : The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report. / Burns, Linda J.; Gajewski, James L.; Majhail, Navneet S.; Navarro, Willis; Perales, Miguel Angel; Shereck, Evan; Selby, George B.; Snyder, Edward L.; Woolfrey, Ann E.; Litzow, Mark R.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 5, 2014, p. 617-621.

Research output: Contribution to journalArticle

Burns, Linda J. ; Gajewski, James L. ; Majhail, Navneet S. ; Navarro, Willis ; Perales, Miguel Angel ; Shereck, Evan ; Selby, George B. ; Snyder, Edward L. ; Woolfrey, Ann E. ; Litzow, Mark R. / Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians : The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report. In: Biology of Blood and Marrow Transplantation. 2014 ; Vol. 20, No. 5. pp. 617-621.
@article{6d14220122e941f1b1e43bbd25536aa8,
title = "Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians: The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report",
abstract = "Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic, and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of HCT as a viable therapeutic option for older patients, those with significant comorbidities, and, with the demonstrated clinical effectiveness of alternative allogeneic donor sources, for those patients without a suitable sibling donor. The National Marrow Donor Program (NMDP) estimates that by 2020, it will facilitate 10,000 transplantations per year, double the number in 2010. To understand the needs of the HCT infrastructure to facilitate this number of transplantations, the NMDP organized the System Capacity Initiative 2020, centered on 6 working groups representing a diverse group of stakeholders. The Physician Workforce Group was tasked with addressing issues relating to recruitment and retention of transplantation physicians. We report here the results of our efforts and future initiatives.",
keywords = "Hematopoietic cell transplantation, Physician workforce, Recruitment, Retention",
author = "Burns, {Linda J.} and Gajewski, {James L.} and Majhail, {Navneet S.} and Willis Navarro and Perales, {Miguel Angel} and Evan Shereck and Selby, {George B.} and Snyder, {Edward L.} and Woolfrey, {Ann E.} and Litzow, {Mark R}",
year = "2014",
doi = "10.1016/j.bbmt.2014.01.028",
language = "English (US)",
volume = "20",
pages = "617--621",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians

T2 - The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report

AU - Burns, Linda J.

AU - Gajewski, James L.

AU - Majhail, Navneet S.

AU - Navarro, Willis

AU - Perales, Miguel Angel

AU - Shereck, Evan

AU - Selby, George B.

AU - Snyder, Edward L.

AU - Woolfrey, Ann E.

AU - Litzow, Mark R

PY - 2014

Y1 - 2014

N2 - Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic, and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of HCT as a viable therapeutic option for older patients, those with significant comorbidities, and, with the demonstrated clinical effectiveness of alternative allogeneic donor sources, for those patients without a suitable sibling donor. The National Marrow Donor Program (NMDP) estimates that by 2020, it will facilitate 10,000 transplantations per year, double the number in 2010. To understand the needs of the HCT infrastructure to facilitate this number of transplantations, the NMDP organized the System Capacity Initiative 2020, centered on 6 working groups representing a diverse group of stakeholders. The Physician Workforce Group was tasked with addressing issues relating to recruitment and retention of transplantation physicians. We report here the results of our efforts and future initiatives.

AB - Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic, and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of HCT as a viable therapeutic option for older patients, those with significant comorbidities, and, with the demonstrated clinical effectiveness of alternative allogeneic donor sources, for those patients without a suitable sibling donor. The National Marrow Donor Program (NMDP) estimates that by 2020, it will facilitate 10,000 transplantations per year, double the number in 2010. To understand the needs of the HCT infrastructure to facilitate this number of transplantations, the NMDP organized the System Capacity Initiative 2020, centered on 6 working groups representing a diverse group of stakeholders. The Physician Workforce Group was tasked with addressing issues relating to recruitment and retention of transplantation physicians. We report here the results of our efforts and future initiatives.

KW - Hematopoietic cell transplantation

KW - Physician workforce

KW - Recruitment

KW - Retention

UR - http://www.scopus.com/inward/record.url?scp=84897965531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897965531&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.01.028

DO - 10.1016/j.bbmt.2014.01.028

M3 - Article

VL - 20

SP - 617

EP - 621

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 5

ER -